Vanguard Group Inc Precigen, Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Precigen, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 9,070,029 shares of PGEN stock, worth $16.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,070,029

Previous 8,795,959 3.12%

Holding current value

$16.3 Million

Previous $13.1 Million 1.72%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$1.17 - $1.62 $320,661 - $443,993	274,070 Added 3.12%	9,070,029 $12.9 Million
Q1 2025 May 09, 2025	BUY	$1.07 - $2.03 $498,050 - $944,900	465,468 Added 5.59%	8,795,959 $13.1 Million
Q4 2024 Feb 11, 2025	BUY	$0.67 - $1.12 $1,574 - $2,632	2,350 Added 0.03%	8,330,491 $9.33 Million
Q3 2024 Nov 13, 2024	BUY	$0.91 - $1.88 $1.43 Million - $2.95 Million	1,568,781 Added 23.21%	8,328,141 $7.91 Million
Q2 2024 Aug 13, 2024	SELL	$1.27 - $1.75 $11,269 - $15,529	-8,874 Reduced 0.13%	6,759,360 $10.7 Million
Q1 2024 May 10, 2024	BUY	$1.21 - $1.75 $24,048 - $34,781	19,875 Added 0.29%	6,768,234 $9.81 Million
Q4 2023 Feb 14, 2024	SELL	$0.89 - $1.41 $180,238 - $285,546	-202,515 Reduced 2.91%	6,748,359 $9.04 Million
Q3 2023 Nov 14, 2023	BUY	$1.08 - $1.85 $140,432 - $240,555	130,030 Added 1.91%	6,950,874 $9.87 Million
Q2 2023 Aug 14, 2023	BUY	$0.96 - $1.4 $121,789 - $177,609	126,864 Added 1.9%	6,820,844 $7.84 Million
Q1 2023 May 15, 2023	BUY	$0.88 - $2.19 $1.59 Million - $3.97 Million	1,811,840 Added 37.11%	6,693,980 $7.1 Million
Q4 2022 Feb 10, 2023	SELL	$1.27 - $2.26 $260,765 - $464,039	-205,327 Reduced 4.04%	4,882,140 $7.42 Million
Q3 2022 Nov 14, 2022	SELL	$1.41 - $2.79 $18,379 - $36,367	-13,035 Reduced 0.26%	5,087,467 $10.8 Million
Q2 2022 Aug 12, 2022	SELL	$1.15 - $2.53 $3.1 Million - $6.82 Million	-2,694,905 Reduced 34.57%	5,100,502 $6.83 Million
Q1 2022 May 13, 2022	SELL	$1.91 - $3.98 $4.34 Million - $9.04 Million	-2,270,908 Reduced 22.56%	7,795,407 $16.4 Million
Q4 2021 Feb 14, 2022	BUY	$3.53 - $5.5 $3.09 Million - $4.81 Million	875,306 Added 9.52%	10,066,315 $37.3 Million
Q3 2021 Nov 12, 2021	BUY	$4.99 - $6.55 $153,232 - $201,137	30,708 Added 0.34%	9,191,009 $45.9 Million
Q2 2021 Aug 13, 2021	BUY	$6.24 - $8.22 $57.2 Million - $75.3 Million	9,160,301 New	9,160,301 $59.7 Million

Others Institutions Holding PGEN

# of Institutions

164

Shares Held

166M

Call Options Held

495K

Put Options Held

979K

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $375M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Precigen, Inc. Transaction History